0000000000364853

AUTHOR

Markus Rohr

showing 8 related works from this author

Anti-inflammatory dihydroxanthones from a Diaporthe species

2021

Abstract In a search for anti-inflammatory compounds from fungi inhibiting the promoter activity of the small chemokine CXCL10 (Interferon-inducible protein 10, IP-10) as a pro-inflammatory marker gene, the new dihydroxanthone methyl (1R, 2R)-1,2,8-trihydroxy-6-(hydroxymethyl)-9-oxo-2,9-dihydro-1H-xanthene-1-carboxylate (2) and the previously described dihydroxanthone AGI-B4 (1) were isolated from fermentations of a Diaporthe species. The structures of the compounds were elucidated by a combination of one- and two-dimensional NMR spectroscopy, mass spectrometry, and calculations using density functional theory (DFT). Compounds 1 and 2 inhibited the LPS/IFNγ induced CXCL10 promoter activity …

Chemokinegenetic structuresmedicine.drug_classClinical BiochemistryInflammation01 natural sciencesBiochemistryMarker geneAnti-inflammatory03 medical and health sciencesDiaporthemedicineCXCL10STAT1Molecular Biology030304 developmental biology0303 health sciencesbiology010405 organic chemistryChemistryTransfectionbiology.organism_classificationMolecular biology0104 chemical sciencesbiology.proteinmedicine.symptomBiological Chemistry
researchProduct

ChemInform Abstract: Synthetic Approaches to Antiinflammatory Macrolactones of the Oxacyclododecindione Type.

2015

A variety of attempts to synthesize oxacyclododecindione macrolactones through carbonylative ring-closure, intramolecular alkyne hydroacyalation, and Ru-catalyzed double bond isomerization fails.

chemistry.chemical_classificationDouble bondchemistryStereochemistryIntramolecular forceSalt metathesis reactionOxacyclododecindioneAlkyneGeneral MedicineIsomerizationChemInform
researchProduct

Total synthesis of two potent anti-inflammatory macrolactones of the oxacyclododecindione type

2015

An esterification/Friedel-Crafts-cyclization approach permitted the first successful synthetic entry into the oxacyclododecindione subclass of the dihydroxyphenylacetic acid lactone-type natural products. This route allowed the preparation of two highly active anti-inflammatory fungal secondary metabolites 14-deoxyoxacyclododecindione and 14-deoxy-4-dechlorooxacyclododecindione as well as their 14-desmethyl analogues.

Macrocyclic CompoundsMolecular StructureChemistrymedicine.drug_classDihydroxyphenylacetic acidStereochemistryAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryTotal synthesisBiochemistrySubclassAnti-inflammatoryLactonesBiochemistryCyclizationmedicineOxacyclododecindionePhysical and Theoretical ChemistryOrganic & Biomolecular Chemistry
researchProduct

A surprising switch in absolute configuration of anti-inflammatory macrolactones.

2016

Oxacyclododecindione-type macrolactones exhibit highly potent anti-inflammatory activities even at nanomolar concentration. After the determination of the relative configuration of the stereocenters at C14 and C15 by total synthesis of 4-dechloro-14-deoxyoxacyclododecindione and 14-deoxyoxacyclododecindione, the absolute configuration has now been assigned by X-ray crystallography. Surprisingly, the absolute configuration is (14S,15R) which differs for C15 from that of the well-known derivatives of (S)-curvularin. The biological activities of both enantiomers of 14-deoxyoxacyclododecindione, obtained by racemic synthesis and optical resolution, were investigated and the ring conformation of…

Models MolecularMacrocyclic CompoundsStereochemistryAnti-Inflammatory AgentsMolecular ConformationStereoisomerism010402 general chemistryRing (chemistry)Crystallography X-Ray01 natural sciencesBiochemistryStereocenterchemistry.chemical_compoundHumansPhysical and Theoretical ChemistryNatural product010405 organic chemistryChemistryOrganic ChemistryAbsolute configurationTotal synthesisStereoisomerismCurvularinHep G2 Cells0104 chemical sciencesEnantiomerOrganicbiomolecular chemistry
researchProduct

Synthetic Approaches to Anti-Inflammatory Macrolactones of the Oxacyclododecindione Type

2015

Various synthetic approaches to the oxacyclododecindione-type macrolactones, known for their potent anti-inflammatory activity, are presented. These include an attempted carbonylative ring closure, a hydroacylation route, and an approach by ring-closing metathesis and double bond isomerization, as well as a strategy including ring-closing metathesis/unsaturation. The last route allowed the preparation of a bioactive analogue of the recently described 14-deoxyoxacyclododecindione.

chemistry.chemical_classificationDouble bondStereochemistrymedicine.drug_classOrganic ChemistryHydroacylationTotal synthesisMetathesisRing (chemistry)Anti-inflammatoryRing-closing metathesischemistrymedicinePhysical and Theoretical ChemistryIsomerizationEuropean Journal of Organic Chemistry
researchProduct

Correction: Total synthesis of two potent anti-inflammatory macrolactones of the oxacyclododecindione type

2015

Correction for ‘Total synthesis of two potent anti-inflammatory macrolactones of the oxacyclododecindione type’ by Johannes Tauber et al., Org. Biomol. Chem., 2015, 13, 7813–7821.

medicine.drug_classStereochemistryChemistryOrganic ChemistrymedicineOxacyclododecindioneTotal synthesisOrganic chemistryPhysical and Theoretical ChemistryBiochemistryAnti-inflammatoryOrganic & Biomolecular Chemistry
researchProduct

Anti-inflammatory tetraquinane diterpenoids from a Crinipellis species.

2016

The small pro-inflammatory 10kDa chemokine CXCL10 (Interferon-inducible protein 10, IP-10) plays an important role in mediating immune responses through the activation and recruitment of leukocytes such as T cells, eosinophils, monocytes and NK cells to the sites of inflammation. Elevated levels of CXCL10 have been associated with chronic inflammatory and infectious diseases and therefore CXCL10 represents an attractive target for the development of new anti-inflammatory drugs. In a search for anti-inflammatory compounds from fungi inhibiting the inducible CXCL10 promoter activity, four new tetraquinane diterpenoids, crinipellin E (1), crinipellin F (2), crinipellin G (3) and crinipellin H …

0301 basic medicineChemokinemedicine.drug_classClinical BiochemistryPharmaceutical ScienceInflammation010402 general chemistry01 natural sciencesBiochemistryAnti-inflammatory03 medical and health sciencesStructure-Activity RelationshipImmune systemDrug DiscoverymedicineCXCL10HumansMolecular BiologyCells CulturedbiologyDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalBiological activityNuclear magnetic resonance spectroscopyTransfectionMolecular biology0104 chemical sciencesChemokine CXCL10030104 developmental biologyBiochemistrybiology.proteinMolecular Medicinemedicine.symptomDiterpenesAgaricalesBioorganicmedicinal chemistry
researchProduct

CCDC 1454207: Experimental Crystal Structure Determination

2016

Related Article: Johannes Tauber, Markus Rohr, Thorsten Walter, Dieter Schollmeyer, Karin Rahn-Hotze, Gerhard Erkel, Till Opatz|2016|Org.Biomol.Chem.|14|3695|doi:10.1039/C6OB00430J

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(4R5S)-14-Chloro-1113-dihydroxy-459-trimethyl-4567-tetrahydro-2H-3-benzoxacyclododecine-210(1H)-dione monohydrateExperimental 3D Coordinates
researchProduct